BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Leggett & Platt
LEG
$1.31B
| $489M | 0.01% |
10,900,290
-54,043
| -0.5% | -$2.6M |
|
1002
UMB Financial
UMBF
$11.1B
| $487M | 0.01% |
5,040,564
-97,453
| -2% | -$8.89M |
|
1003
Rayonier
RYN
$6.55B
| $487M | 0.01% |
15,057,876
-12,643
| -0.1% | -$423K |
|
1004
Steven Madden
SHOO
$3.55B
| $485M | 0.01% |
12,066,524
-241,524
| -2% | -$9.98M |
|
|
ATH
1005
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $485M | 0.01% |
7,035,092
+56,315
| +0.8% | +$3.75M |
|
1006
Bentley Systems
BSY
$10.6B
| $484M | 0.01% |
7,984,567
+2,838,418
| +55% | +$181M |
|
1007
iShares National Muni Bond ETF
MUB
$45.9B
| $484M | 0.01% |
4,167,606
+380,203
| +10% | +$44.6M |
|
|
HI
1008
DELISTED
Hillenbrand
HI
| $483M | 0.01% |
11,333,606
-693,108
| -6% | -$30.4M |
|
1009
First Hawaiian
FHB
$3.35B
| $481M | 0.01% |
16,386,452
-702,376
| -4% | -$19.5M |
|
1010
Insight Enterprises
NSIT
$4.38B
| $481M | 0.01% |
5,337,820
-444,037
| -8% | -$43M |
|
1011
Nice
NICE
$5.97B
| $480M | 0.01% |
1,689,823
+13,121
| +0.8% | +$3.64M |
|
1012
Vontier
VNT
$4.74B
| $479M | 0.01% |
14,242,140
-647,477
| -4% | -$22M |
|
1013
PVH
PVH
$4.04B
| $478M | 0.01% |
4,647,644
-228,546
| -5% | -$24.6M |
|
|
NVTA
1014
DELISTED
Invitae Corporation
NVTA
| $478M | 0.01% |
16,803,587
-1,049,108
| -6% | -$30.7M |
|
|
AQUA
1015
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $476M | 0.01% |
12,664,663
+2,774,163
| +28% | +$100M |
|
1016
Workiva
WK
$3.54B
| $475M | 0.01% |
3,373,078
+555,960
| +20% | +$75.3M |
|
1017
BridgeBio Pharma
BBIO
$16.5B
| $475M | 0.01% |
10,141,311
+640,990
| +7% | +$34.4M |
|
|
ETRN
1018
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $475M | 0.01% |
46,843,699
-1,931,171
| -4% | -$17M |
|
1019
Cytokinetics
CYTK
$10.4B
| $474M | 0.01% |
13,262,947
+1,608,545
| +14% | +$47.4M |
|
1020
Helmerich & Payne
HP
$3.71B
| $471M | 0.01% |
17,196,735
-531,970
| -3% | -$14.9M |
|
1021
ABM Industries
ABM
$2.84B
| $471M | 0.01% |
10,471,218
-1,127,885
| -10% | -$52.2M |
|
1022
Interactive Brokers
IBKR
$39.8B
| $471M | 0.01% |
30,219,916
+986,048
| +3% | +$15.5M |
|
1023
Simmons First National
SFNC
$3.39B
| $471M | 0.01% |
15,918,989
-36,064
| -0.2% | -$1.02M |
|
|
MRTX
1024
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $470M | 0.01% |
2,658,210
-369,295
| -12% | -$59.4M |
|
1025
WD-40
WDFC
$3.15B
| $470M | 0.01% |
2,030,670
-39,425
| -2% | -$9.46M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.